Skip Navigation
Archive

NIAID Archive

Important note: Information on this page was accurate at the time of publication. This page is no longer being updated.
​​
NIH HHS News Release Logo

National Institute of Allergy and
Infectious Diseases (NIAID)
http://www.niaid.nih.gov

FOR IMMEDIATE RELEASE
Monday, Sept. 21, 1998

Media Contact:
James Hadley
(301) 402-1663
niaidnews@niaid.nih.gov
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

NIAID and NIEHS Recruit for National Cooperative Inner-CityStudy to Reduce Asthma Severity in Children

Investigators supported by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Environmental Health Sciences (NIEHS) are recruiting children with moderate to severe asthma for a large nationwide multicenter study.

The study, in seven sites in inner cities across the United States, aims to reduce the severity of asthma among low-income children. Participating research institutions are located in Boston, Mass.; Chicago, Ill.; Dallas, Texas; New York, N.Y. (Bronx and Manhattan); Seattle, Wash.; and Tucson, Ariz.

Asthma has been increasing in the United States over several decades. This increase is most apparent among children, especially those living in inner cities. Approximately 15 million Americans suffer from asthma. Annually, in the United States about 500,000 asthma-related hospitalizations occur and 5,000 people die.

Anthony S. Fauci, M.D., NIAID director, says, "This study affirms our commitment to learn more about how to reduce asthma in our inner-city pediatric populations, children primarily of African American and Hispanic heritage. Our goal is to aid children and their families by providing valuable insights on managing a child’s asthma through education, environmental controls and behavior modification."

NIEHS Director Kenneth Olden, Ph.D., adds, "We want to enable inner-city families to help their kids avoid asthma attacks by modifying their environment. That means reducing the allergens – the things the youngsters are allergic to – with such things as plastic covers on their pillows and mattresses, air filters, and the elimination of mold and insects."

Focusing on more than 1,000 children between the ages of 4 and 12 with moderate to severe asthma, the study will test the effectiveness of two interventions. One intervention entails a novel communication/physician education system in which patient information on asthma severity, medication use and health care utilization, obtained through bimonthly phone interviews, will be interpreted according to the asthma care guidelines developed by the National Asthma Education and Prevention Program. This information will be provided to the asthma patients’ primary care physicians, and the study will evaluate the value of this exchange in improving medical care.

The other intervention involves educating families about reducing indoor allergens and passive cigarette smoke, which may trigger asthma attacks. In addition, extensive allergen reduction measures will be undertaken at no cost to participating families. These measures will include professional cockroach extermination; extensive and repeated cleaning; repair of cracks and pest entry points; encasing of mattresses and pillows in dust-proof or allergen-proof covers (zippered plastic); and using air filters to reduce airborne allergens, including allergens from household pets (such as cats and dogs) and fungal allergens. Follow-up home evaluations will assess the impact of the intervention on the levels of indoor allergens. The effectiveness of the intervention will be assessed by its capacity to reduce the severity of asthma in these children.

In addition to NIAID and NIEHS, this study is supported by the National Institutes of Health (NIH) Pediatric Research Initiative. NIH is an agency of the U.S. Department of Health and Human Services.

NIAID, a component of NIH located in Bethesda, Md., conducts and supports research aimed at preventing, diagnosing and treating illnesses such as AIDS and other sexually transmitted diseases, tuberculosis, asthma and allergies.

NIEHS, another component of NIH in Research Triangle Park, N.C., conducts and supports research to understand the impact of the environment on human diseases such as asthma, translates this research into strategies to prevent disease and promote health, and communicates this information to the public.

The NIH Pediatric Research Initiative is a continuing effort to strengthen the pediatric biomedical research portfolio, encourage collaborative efforts across institutes in high priority areas, and to assure expanding opportunities for advancement in scientific investigations involving children.

NIAID/NIEHS National Cooperative Inner-City Asthma Study

Those interested in participating in the study should contact the institution in their local community.

  • Ellen Crain, M.D., Ph.D.
    Pediatric Emergency Medicine
    Albert Einstein College of Medicine
    1300 Morris Park Avenue
    Bronx, NY 10461
    718/918-4395
  • George T. O'Connor, M.D.
    Pulmonary Center
    Boston University School of Medicine
    80 E. Concord Street, K603
    Boston, MA 02118
    617/636-4860
  • Richard Evans III, M.D., M.P.H.
    Department of Pediatrics
    Division of Allergy
    Children's Memorial Hospital
    990 W. Fullerton
    Suite 200
    Chicago, IL 60614
    773/404-4678
  • Meyer Kattan, M.D.
    Department of Pediatrics
    Mount Sinai School of Medicine
    Box 1202
    One Gustave L. Levy Place
    New York, NY 10029
    212/241-7788
  • James W. Stout, M.D., M.P.H.
    Odessa Brown Children's Clinic
    2101 E. Yesler Way
    Seattle, WA 98112
    206/527-1200
  • Wayne Morgan, M.D.
    University of Arizona Health Sciences Center
    1501 N. Campbell Avenue
    Tucson, AZ 85724
    520/626-7780
  • Rebecca Gruchalla, M.D., Ph.D.
    Department of Internal Medicine
    Division of Allergy and Immunology
    University of Texas Southwestern Medical Center
    5323 Harry Hines Blvd.
    Dallas, TX 75235-8859
    214/648-5436
  • (Data Coordinating Center)
    Herman E. Mitchell, Ph.D.
    Rho, Inc.
    121 S. Estes Drive, Suite 100
    Chapel Hill, NC 27514
    910/932-6500 ext. 223

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH...Turning Discovery Into Health ®

back to top


Archive

NIAID Archive

Important note: Information on this page was accurate at the time of publication. This page is no longer being updated.
​​​​

Last Updated September 21, 1998